W.L.Gore & Associates   Report issue

For profit Phase 2 Phase 3
Founded: Newark NJ United States (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2020
NCT04100135
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Avobis Bio, LLC | W.L.Gore & Associates

Active Ingredients

Drugs in Phase 3 Trials (2)

clopidogrel (plavix) (1 trial)

prasugrel (effient) (1 trial)

Drugs in Phase 2 Trials (1)

avb-114 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Foramen Ovale, Patent (Phase 3)

Migraine Disorders (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3